| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,565 |
6,539 |
$412K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,104 |
1,751 |
$127K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,712 |
1,652 |
$114K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,044 |
1,016 |
$73K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
700 |
621 |
$55K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
634 |
615 |
$49K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,701 |
2,582 |
$49K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,087 |
3,913 |
$35K |
| 87428 |
|
556 |
541 |
$31K |
| 99051 |
|
489 |
479 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
301 |
264 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
865 |
841 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
729 |
714 |
$7K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
119 |
74 |
$6K |
| 90473 |
|
407 |
392 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
133 |
130 |
$4K |
| T1015 |
Clinic visit/encounter, all-inclusive |
29 |
24 |
$3K |
| 99460 |
|
66 |
62 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
279 |
141 |
$3K |
| 99215 |
Prolong outpt/office vis |
19 |
14 |
$2K |
| 0072A |
|
29 |
29 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
45 |
45 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
31 |
25 |
$466.23 |
| 0051A |
|
12 |
12 |
$429.39 |
| 88720 |
|
17 |
13 |
$63.89 |
| 90686 |
|
411 |
377 |
$19.30 |
| 90670 |
|
104 |
51 |
$4.95 |
| 90723 |
|
47 |
24 |
$2.30 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$1.82 |